BeOne Medicines BEIGF
NASDAQ BEIGF
$21.95 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

BeOne Medicines (BEIGF) Prepaid Assets (2015 - 2026)

BeOne Medicines' (BEIGF) quarterly Prepaid Assets came in at $329.0 million in Q2 2026, up 17.28% year-over-year from $280.5 million in Q2 2025, and up 73.15% quarter-over-quarter from $190.0 million in Q1 2026.

Analysis

BeOne Medicines (BEIGF) Prepaid Assets (2015 - 2026) Analysis & Trends

BeOne Medicines (BEIGF) has reported Prepaid Assets for 12 consecutive years, with $329.0 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Prepaid Assets rose 17.28% year-over-year to $329.0 million in Q2 2026; TTM through Jun 2026 was $329.0 million, a 17.28% increase from a year earlier, with the FY2025 full-year figure at $212.8 million, up 10.28% from the prior year.
  • Prepaid Assets was $329.0 million for Q2 2026 at BeOne Medicines, up from $190.0 million in the prior quarter.
  • Over five years, Prepaid Assets peaked at $329.0 million in Q2 2026 and troughed at $168.2 million in Q1 2025.
  • A 5-year average of $235.0 million and a median of $232.2 million in 2024 frame the typical range for Prepaid Assets.
  • Across the five-year window, Prepaid Assets soared 55.45% in 2022 and dropped 27.43% in 2025, its largest moves.
  • Over 5 years, Prepaid Assets stood at $216.6 million in 2022, then increased by 18.89% to $257.5 million in 2023, then retreated by 25.07% to $192.9 million in 2024, then grew by 10.28% to $212.8 million in 2025, then soared by 54.63% to $329.0 million in 2026.
  • The last three Prepaid Assets figures came in at $329.0 million (Q2 2026), $190.0 million (Q1 2026), and $212.8 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.95 Bn 625.20 Bn 17.26 Bn
2 AbbVie 441.39 Bn 434.82 Bn 12.70 Bn
3 Merck 366.72 Bn 359.58 Bn 12.21 Bn
4 Novartis Ag 266.68 Bn 258.99 Bn 11.24 Bn
5 Pfizer 159.20 Bn 147.50 Bn 10.94 Bn
6 Sanofi 52.43 Bn 45.05 Bn 10.79 Bn
7 Revolution Medicines 44.08 Bn 44.08 Bn -
8 Incyte 25.50 Bn 20.96 Bn 1.57 Bn
9 United Therapeutics 21.54 Bn 18.88 Bn 683.80 Mn
10 BeOne Medicines 2.48 Bn -2.62 Bn 1.53 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 328.98 Mn
Mar 31, 2026 190.00 Mn
Dec 31, 2025 212.75 Mn
Sep 30, 2025 232.64 Mn
Jun 30, 2025 280.52 Mn
Mar 31, 2025 168.18 Mn
Dec 31, 2024 192.92 Mn
Sep 30, 2024 209.08 Mn
Jun 30, 2024 273.66 Mn
Mar 31, 2024 231.74 Mn
Dec 31, 2023 257.47 Mn
Sep 30, 2023 241.66 Mn
Jun 30, 2023 255.05 Mn
Mar 31, 2023 264.84 Mn
Dec 31, 2022 216.55 Mn
Sep 30, 2022 199.77 Mn
Jun 30, 2022 207.38 Mn
Mar 31, 2022 266.44 Mn
Dec 31, 2021 270.17 Mn
Sep 30, 2021 235.02 Mn